Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study
- Status
- COMPLETED
- Phase
- PHASE2
Study of S-1 in Combination With Radiotherapy in Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- COMPLETED
- Phase
- PHASE1
Oral Rigosertib for Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Role of Esophagectomy in Complete Responders to CCRT
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus
- Status
- COMPLETED
- Phase
- PHASE2
Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal Cancer
- Status
- COMPLETED
- Phase
- NA
Genome-wide Association Study
- Status
- WITHDRAWN
- Phase
- N/A
Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0
- Status
- UNKNOWN
- Phase
- PHASE3
A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
- Status
- COMPLETED
- Phase
- N/A